Latest News Feed
BioLargo sponsors legal and technical forum on PFAS contamination; company's PFAS remediation technology to be featured on a technical panel alongside leading environmental engineering firms, followed by a special screening of the film "Revealed: How to Poison a Planet."
A Year of Disciplined Execution as BioLargo Gained Commercialization for Several Business Segments with $3.9 Million Cash Balance at Year End
Clinical Experience Presented at Boswick Symposium Shows Rapid Wound Transformation, Enhanced Healing, and Strong Antimicrobial Performance Across Multiple Wound Types
Initial Distribution Launch Marks Transition to Revenue-Generating Operations
Lake Stockholm, NJ AEC System Delivered and Preparing to Go Live
$4.5 Million Cash Balance at Quarter-End as High-Impact Technology Portfolio Advances
Distribution Agreement Brings Innovative Copper-Iodine Complex Technology to Wound Care Market
Nine-count complaint alleges fraud, false advertising, breach of contract, and patent infringement
Cellinity battery cell technology, BioLargo's role in the global AI infrastructure investment cycle, and a general corporate update are featured in the presentation.
Cellinity is a breakthrough battery storage solution for AI infrastructure that eliminates the need for rare earth elements
Initial Commercialization Targeting $732 Million Wound Care Market is Expected in Late 2025 or Early 2026
Pooph owes BioLargo $3.8 million
Significantly Advances Energy Technologies and Clyra Medical Technologies
Letter to stockholders
No immediate intention to proceed with a reverse stock split - "This vote empowers us to be ready when the time is right."
Case studies show the company's innovative capture + destruction two-step approach can offer a scalable, economically feasible solution for PFAS elimination from drinking water, wastewater, and landfill leachate, capable of reducing lifecycle costs by over 80%
Revenues up 45% over prior year
Company will report on successful removal and destruction of PFAS from landfill leachate at the Air & Waste Management Association's - The Science of PFAS Conference on March 12, 2025
Continued Strong Revenue Growth; Zero Share Dilution in 2nd Half of 2024
Q2 2024 revenues grew 247% compared to same three months last year
USAF work now amounts to over $100,000 in revenue per month.